

This a model from the article:  
**Modeling the effects of treating diabetic wounds with engineered skin substitutes.**   
Waugh HV, Sherratt JA. _Wound Repair Regen_ 2007 Jul-Aug;15(4):556-65
[17650100](http://www.ncbi.nlm.nih.gov/pubmed/17650100) ,  
**Abstract:**   
In this paper, a novel mathematical model of wound healing in both normal and
diabetic cases is presented, focusing upon the effects of adding two currently
available commercial engineered skin substitute therapies to the wound
(Apligraf) and Dermagraft). Our work extends a previously developed model,
which considers inflammatory and repair macrophage dynamics in normal and
diabetic wound healing. Here, we extend the model to include equations for
platelet-derived growth factor concentration, fibroblast density, collagen
density, and hyaluronan concentration. This enables us to examine the
variation of these components in both normal and diabetic wound healing cases,
and to model the treatment protocols of these therapies. Within the context of
our model, we find that the key component to successful healing in diabetic
wounds is hyaluronan and that the therapies work by increasing the amount of
hyaluronan available in the wound environment. The time-to-healing results
correlate with those observed in clinical trials and the model goes some way
to establishing an understanding of why diabetic wounds do not heal, and how
these treatments affect the diabetic wound environment to promote wound
closure.

This model was taken from the [CellML
repository](http://www.cellml.org/models) and automatically converted to SBML.  
The original model was: [ **Waugh HV, Sherratt JA. (2007) - version=1.0**
](http://models.cellml.org/exposure/cac0806739b31f9022645098c1e0c1dc)  
The original CellML model was created by:  
**Catherine Lloyd**   
c.lloyd@auckland.ac.nz  
The University of Auckland  

This model originates from BioModels Database: A Database of Annotated
Published Models (http://www.ebi.ac.uk/biomodels/). It is copyright (c)
2005-2011 The BioModels.net Team.  
To the extent possible under law, all copyright and related or neighbouring
rights to this encoded model have been dedicated to the public domain
worldwide. Please refer to [CC0 Public Domain
Dedication](http://creativecommons.org/publicdomain/zero/1.0/) for more
information.

In summary, you are entitled to use this encoded model in absolutely any
manner you deem suitable, verbatim, or with modification, alone or embedded it
in a larger context, redistribute it, commercially or not, in a restricted way
or not..  
  
To cite BioModels Database, please use: [Li C, Donizelli M, Rodriguez N,
Dharuri H, Endler L, Chelliah V, Li L, He E, Henry A, Stefan MI, Snoep JL,
Hucka M, Le Nov√®re N, Laibe C (2010) BioModels Database: An enhanced, curated
and annotated resource for published quantitative kinetic models. BMC Syst
Biol., 4:92.](http://www.ncbi.nlm.nih.gov/pubmed/20587024)

